Cardinal Health Inc. stock (US14149Y1082): steady trading as investors digest recent guidance and valuation metrics

Cardinal Health Inc. shares continue to trade in a tight range on the New York Stock Exchange as investors assess the company’s latest profit guidance and earnings metrics in the United States healthcare distribution market.

Cardinal Health Inc. shares were little moved in recent U.S. trading, with the New York Stock Exchange-listed stock changing hands around the USD 190–200 area as investors continue to evaluate the company’s latest profit guidance and earnings trajectory in the United States healthcare sector, according to Robinhood data as of 12/09/2025 and other market snapshots.Robinhood as of 12/09/2025

The stock traded near USD 198–199 on 12/09/2025 on the NYSE, based on indicative prices from Upstox and Robinhood, leaving Cardinal Health Inc. valued at roughly USD 46 billion and keeping the company firmly in the large-cap bracket in its U.S. home market.Upstox as of 12/09/2025 The healthcare products distributor remains a key component of the domestic supply chain, and U.S. investors continue to benchmark it against broader U.S. equity indices as they weigh its role in hospitals and pharmacies.

The company has also drawn attention from U.S. commentators after it raised full-year profit guidance in its most recent fiscal update for fiscal 2025, even as the share price showed a muted reaction in subsequent sessions, according to a Benzinga summary dated 04/26/2025.Benzinga as of 04/26/2025 That move in guidance highlighted management’s confidence in underlying demand across U.S. healthcare settings, even if short-term share price performance has been more subdued.

The stock’s valuation remains in focus in its home market of the United States, with Cardinal Health Inc. trading at a price-to-earnings ratio of about 30 on 12/09/2025 and offering a dividend yield of roughly 1.0 percent at that time, based on Robinhood metrics.Robinhood as of 12/09/2025 These figures give U.S. retail investors a reference point when comparing the stock to other healthcare distributors and the wider U.S. equity market.

As of: 05/29/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Cardinal Health
• Sector/industry: Healthcare distribution and services
• Headquarters/country: Dublin, United States
• Core markets: United States healthcare providers, pharmacies and medical facilities
• Key revenue drivers: Pharmaceutical distribution and medical products for hospitals, health systems and retail pharmacies
• Home exchange/listing venue: New York Stock Exchange (CAH)
• Trading currency: USD

Cardinal Health Inc.: core business model

Cardinal Health Inc. operates as a large-scale healthcare logistics and products group, generating most of its revenue by supplying pharmaceuticals and medical items to U.S. hospitals, health systems and pharmacies under long-term distribution and service agreements.

Valuation metrics and multiples for Cardinal Health Inc.

Valuation metrics for Cardinal Health Inc. have been an important lens for investors following the company’s recent guidance updates and earnings releases in the United States healthcare market. On 12/09/2025, Robinhood data showed the stock trading at approximately USD 197.90 per share with a market capitalization of about USD 46.35 billion, a price-to-earnings ratio near 30.6 and a dividend yield close to 1.0 percent, giving investors a snapshot of how the equity was priced relative to its reported earnings and income distribution at that point in time.Robinhood as of 12/09/2025

These valuation markers are often compared with other U.S.-listed healthcare distributors and service providers, where investors may look at differences in earnings multiples and yields to gauge how the market prices Cardinal Health Inc. relative to peers with similar exposure to hospital, pharmacy and medical facility demand. Against the backdrop of its updated profit guidance, which Benzinga highlighted on 04/26/2025 after the company raised its earnings outlook for fiscal 2025, such valuation data helps market participants assess whether the current share price levels adequately reflect expectations for margins and cash generation in the broader U.S. healthcare ecosystem.Benzinga as of 04/26/2025

Conclusion

Cardinal Health Inc. continues to trade steadily on the New York Stock Exchange within a relatively narrow band, as investors in the United States weigh the company’s raised profit guidance against its current earnings multiple and dividend yield. The valuation metrics reported in December 2025, including a price-to-earnings ratio around 30 and a 1.0 percent dividend yield, provide a reference point for how the market has been pricing its healthcare distribution franchise.

Against this backdrop, U.S. market participants are likely to keep focusing on how future earnings releases and guidance updates align with these valuation levels, particularly as Cardinal Health Inc. operates at the heart of the U.S. healthcare supply chain serving hospitals, health systems and pharmacies. Share-price responses to upcoming data points will help clarify whether the current trading range and valuation multiples remain sustainable over time.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.